H1 antagonist
H 1 antagonists, also called H 1 blockers, are a class of medications that block the action of histamine at the H 1 receptor, helping to relieve allergic reactions.
≈ 5 min read
H1 antagonist. encyclopegia.org, snapshot enwiki-001373696769. /a/h1-antagonist
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
H 1 antagonists, also called H 1 blockers, are a class of medications that block the action of histamine at the H 1 receptor, helping to relieve allergic reactions. Agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines; other agents may have antihistaminergic action but are not true antihistamines.
In common use, the term "antihistamine" refers only to H 1 -antihistamines. Virtually all H 1 -antihistamines function as inverse agonists at the histamine H 1 -receptor, as opposed to neutral antagonists, as was previously believed.
Medical uses
H 1 -antihistamines are used clinically to treat histamine-mediated allergic conditions. These indications may include: Allergic rhinitis Allergic conjunctivitis Allergic dermatological conditions (contact dermatitis) Rhinorrhea (runny nose) Urticaria Angioedema Diarrhea Pruritus (atopic dermatitis, insect bites) Anaphylactic or anaphylactoid reactions—adjunct only First-generation H 1 -antihistamines can act on the central nervous system (CNS).
As a result, they are also used for: Nausea, vomiting, and motion sickness Sedation H 1 -antihistamines can be administered topically (through the skin, nose, or eyes) or systemically, based on the nature of the allergic condition. The authors of the American College of Chest Physicians Updates on Cough Guidelines (2006) recommend that, for cough associated with the common cold, first-generation antihistamine-decongestants are more effective than newer, non-sedating antihistamines.
First-generation antihistamines include diphenhydramine (Benadryl), carbinoxamine (Clistin), clemastine (Tavist), chlorpheniramine (Chlor-Trimeton), and brompheniramine (Dimetane). However, a 1955 study of "antihistaminic drugs for colds," carried out by the U.S. Army Medical Corps, reported that "there was no significant difference in the proportion of cures reported by patients receiving oral antihistaminic drugs and those receiving oral placebos.
Furthermore, essentially the same proportion of patients reported no benefit from either type of treatment."
Side effects
Adverse drug reactions are most commonly associated with the first-generation H 1 -antihistamines. This is due to their relative lack of selectivity for the H 1 -receptor and their ability to cross the blood–brain barrier. The most common adverse effect is sedation; this "side-effect" is utilized in many OTC sleeping-aid preparations.
Other common adverse effects in first-generation H 1 -antihistamines include dizziness, tinnitus, blurred vision, euphoria, incoordination, anxiety, increased appetite leading to weight gain, insomnia, tremor, nausea and vomiting, constipation, diarrhea, dry mouth, and dry cough. Infrequent adverse effects include urinary retention, palpitations, hypotension, headache, hallucination, psychosis and erectile dysfunction.
The newer, second-generation H 1 -antihistamines are far more selective for peripheral histamine H 1 -receptors and have a better tolerability profile compared to the first-generation agents. The most common adverse effects noted for second-generation agents include drowsiness, fatigue, headache, nausea, and dry mouth.
Continuous and/or cumulative use of anticholinergic medications, including first-generation antihistamines, is associated with a higher risk for cognitive decline and dementia in older people.
Anti-allergy activity
In type I hypersensitivity allergic reactions, an allergen (a type of antigen) interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the allergen cross-links Immunoglobulin E, tyrosine kinases rapidly signal into the cell, leading to cell degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil.
Once released, the histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H 1 -receptors, produces pruritus, vasodilation, hypotension, flushing, headache, bradycardia, bronchoconstriction, increase in vascular permeability and potentiation of pain.
While H 1 -antihistamines help against these effects, they work only if taken before contact with the allergen. In severe allergies, such as anaphylaxis or angioedema, these effects may be of life-threatening severity. Additional administration of epinephrine, often in the form of an autoinjector, is required by people with such hypersensitivities.
Sedative and hypnotic activity
Other non-selective sedating antihistamines used as hypnotics include the antihistamines chlorpheniramine and promethazine, the antidepressants amitriptyline, trimipramine, and trazodone, and the antipsychotics olanzapine, risperidone, and chlorpromazine, among others.
First-generation (unselective)
These are the oldest H 1 -antihistaminergic drugs and are relatively inexpensive and widely available. They are effective in the relief of allergic symptoms, but are typically moderately to highly potent muscarinic acetylcholine receptor (anticholinergic) antagonists as well. These agents also commonly have action at α-adrenergic receptors and/or 5-HT receptors.
This lack of receptor selectivity is the basis of the poor tolerability profile of some of these agents, especially when compared with the second-generation H 1 -antihistamines. Patient response and occurrence of adverse drug reactions vary greatly between classes and between agents within classes.
Classes
The first H 1 -antihistamine discovered was piperoxan, by Ernest Fourneau and Daniel Bovet (1933) in their efforts to develop a guinea pig animal model for anaphylaxis at the Pasteur Institute in Paris. Bovet went on to win the 1957 Nobel Prize in Physiology or Medicine for his contribution.
Following their discovery, the first-generation H 1 -antihistamines were developed in the following decades. They can be classified on the basis of chemical structure, and agents within these groups have similar properties. For details about chemical structure, see § Chemical structure below.
Over-the-counter
H 1 receptor antagonists that are approved for over-the-counter sale in the United States include the following.
First-generation
Common/marketed: Brompheniramine (Dimetapp, Dimetane) Chlorpheniramine (Chlor-Trimeton) Dimenhydrinate (Dramamine, Gravol) – combination of diphenhydramine and 8-chlorotheophylline Diphenhydramine (Benadryl) Doxylamine (Unisom) Uncommon/discontinued: Chlorcyclizine Dexbrompheniramine Dexchlorpheniramine Methapyrilene Phenindamine Pheniramine Phenyltoloxamine Pyrilamine Thenyldiamine Thonzylamine Triprolidine
Second-generation
Cetirizine (Zyrtec) Fexofenadine (Allegra) Levocetirizine (Xyzal) Loratadine (Alavert, Claritin)
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373696769 under CC BY-SA 4.0; modifications have been made.